MedTrace Logo

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Initially Node Positive Breast Cancer Patients, Could it Omit Axillary Dissection ?

NCT06130241 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-11-14

No results posted yet for this study

Summary

The aim of this study is to determine the accuracy and safety of SLNB after neoadjuvant chemotherapy.

Conditions

  • Sentinel Lymph Node

Interventions

PROCEDURE

sentinle lymphnode biopsy

intraoperative sentinle lymphnode biopsy

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Mahmoud thabet, Assistant lecture · Assiut University

  • negm eldein abulnaga, lecturer of general surgery · Assiut University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-30
Primary Completion
2025-01-01
Completion
2025-04-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06130241 on ClinicalTrials.gov